Tobias Frank

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease

Jens A. Wagner, Sergey Ryazanov, Andrei Leonov et al. · Acta Neuropathologica · 2013 · 456 citations · Full text

Life Sciences, Medicinal Chemistry, Neuroscience +17

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease

Lars Tönges, Tobias Frank, Lars Tatenhorst et al. · Brain · 2012 · 171 citations · Full text

Life Sciences, Neurology, Molecular Neurobiology +16

Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease

Julia Benkert, Shoumik Roy, Dayne Beccano-Kelly et al. · Nature Communications · 2019 · 102 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

Albert C. Ludolph, Joachim Schuster, Johannes Dorst et al. · The Lancet Neurology · 2018 · 80 citations · Full text

Medicine, Neurology, Pharmacology +12

Both systemic and local application of Granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy

Tobias Frank, Johannes C. M. Schlachetzki, Bettina Göricke et al. · BMC Neuroscience · 2009 · 40 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16